Retatrutide (LY3437943), marketed here as Reta-Solution, is an investigational multi-receptor peptide agonist that targets the receptors for GIP, GLP-1 and glucagon, and is used in experimental models of obesity, glycemic control and metabolic regulation
This stress can lead to various complications, including preeclampsia, gestational diabetes, and fetal growth restrictions
Saneto RP et al
The peptides main effect on weight occurs through appetite suppression mediated by GLP-1 receptor start in the hypothalamus and other brain regions involved in appetite control
PLoS One 13 , e0196455 (2018)
Each time you experience one of these stressors, your body releases cortisol to help cope with the stress